Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) EPS (Weighted Average and Diluted) (2022 - 2025)

Korro Bio (KRRO) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$1.92 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) rose 14.29% year-over-year to -$1.92, compared with a TTM value of -$9.42 through Sep 2025, down 106.69%, and an annual FY2024 reading of -$9.37, up 82.35% over the prior year.
  • EPS (Weighted Average and Diluted) was -$1.92 for Q3 2025 at Korro Bio, up from -$2.75 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $147.86 in Q4 2023 and bottomed at -$225.59 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 4 years is -$17.78, with a median of -$2.43 recorded in 2024.
  • The sharpest move saw EPS (Weighted Average and Diluted) soared 165.54% in 2023, then plummeted 622.58% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$225.59 in 2022, then soared by 165.54% to $147.86 in 2023, then plummeted by 101.53% to -$2.26 in 2024, then grew by 15.04% to -$1.92 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for KRRO at -$1.92 in Q3 2025, -$2.75 in Q2 2025, and -$2.49 in Q1 2025.